TGM2 and interstitial lung disease: Particularly, we further uncovered the specific mechanisms of OS in controlling the progression of RA and RA‐ILD, laying a foundation for the clinical translation of OS as an effective drug and TGM2 as a promising target applied for RA and RA‐ILD treatments.